| |
The
challenge of and need for drug surveillance (including HIV testing
infrastructure and the difficulty in selecting second- and
third-line antiretrovirals) as well as the importance of adherence
in preventing drug resistance have emerged as critical issues for
the Caribbean region. This track presents the emerging issues in the
Caribbean
of drug
resistance, virologic epidemiology, and different viral
genotypes/subtypes.
Additionally,
in the absence of a definitive curative therapy, the search for an
HIV vaccine is essential. The
Caribbean, the region with the second highest incidence of
HIV/AIDS in the world, has been selected to participate in
international vaccine trial programs with five trial sites. The
Dominican
Republic,
Haiti,
Jamaica,
Puerto
Rico, and
Trinidad
and Tobago
receive
funding from a number of international organizations to conduct
clinical trials. Finding a vaccine and ultimately a cure for
HIV/AIDS has become a central preoccupation for people living with
HIV/AIDS, governments, researchers, and health care providers—not
only in the region, but throughout the world.
This
track also addresses research findings on vaccine trials, updates on
the latest vaccine research, and various perspectives on the latest
research. State-of-the-art interventions and capacity building to
support the conduct of clinical trials in the Caribbean
and
ethical issues associated with vaccine research will also be
discussed.
|
